Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
MedTech
Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD
Three diabetes tech companies made the case in Barcelona for their CGMs and insulin pumps as they look to expand their reach in Type 2 diabetes.
Conor Hale
Mar 12, 2026 1:07pm
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Feb 2, 2026 3:01pm
Arrowhead takes aim at obesity with early gene silencing data
Jan 6, 2026 10:19am
GlucoModicum touts needle-free Sofio glucose monitor patch
Dec 18, 2025 2:06pm
Novo expands pivotal program after amycretin shines in diabetes
Nov 25, 2025 7:44am
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Nov 19, 2025 9:45am
